Armlupeg PFS Q Code: Q5169
Injection, pegfilgrastim-unne (armlupeg), biosimilar, 0.5 mg
Q4 2026 Medicare Payment Limit for Q5169, effective October 1, 2026: $519.481 per HCPCS billing unit. CMS publishes none for Q3 2026. From CMS's final file.
Drug & Product Overview
About Armlupeg PFS
Armlupeg PFS is a medication aligned to the HCPCS Q Code: Q5169 for billing, pricing, and reimbursement purposes in the United States. It is an Oncology Colony Stimulating Factor drug administered via the subcutaneous route and manufactured by Valorum Biologics.
Manufacturers, reach out to us to add more information.
NDC Code Information
Based on publicly available CMS files. The list of NDCs below is not exhaustive.
| NDC Code | Package | Manufacturer | HCPCS Units | WAC | AWP |
|---|---|---|---|---|---|
| 70748-0273-01 | 6 MG / 0.6 MLArmlupeg Subcutaneous Injection 6 MG/0.6ML - 1 SYRINGE in 1 CARTON (70748-273-01) / .6 mL in 1 SYRINGE | Valorum Biologics, LLC | 12 | $6,097.08 $508.09 / unit | $7,316.50 $609.708 / unit |
Effective 4/1/26 (WAC & AWP)
Armlupeg PFS Pricing & Reimbursement
Historical Graphing and Billing Calculator
Estimates only. Payer reimbursement varies by contract, site of care, and sequestration.
Pegfilgrastim Biosimilar Information:
Armlupeg PFS Approval Date: November 28, 2025
| Product Name | HCPCS Code | Active Ingredient | BLA Type |
|---|---|---|---|
| Neulasta | J2506 | Pegfilgrastim | 351(a) Originator Product |
| Fulphila | Q5108 | Pegfilgrastim | 351(k) Biosimilar |
| Udenyca | Q5111 | Pegfilgrastim | 351(k) Biosimilar |
| Ziextenzo | Q5120 | Pegfilgrastim | 351(k) Biosimilar |
| Nyvepria | Q5122 | Pegfilgrastim | 351(k) Biosimilar |
| Fylnetra | Q5130 | Pegfilgrastim | 351(k) Biosimilar |
| Stimufend | Q5127 | Pegfilgrastim | 351(k) Biosimilar |
| Armlupeg | Q5169 | Pegfilgrastim | 351(k) Biosimilar |
| Ennumo | N/A | Pegfilgrastim | 351(k) Biosimilar |
Armlupeg PFS CPT Administration Codes
The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.
| CPT Code | Description |
|---|---|
| 96372 | Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular |
This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →
Armlupeg PFS Clinical Information
Indications and drug classification.
This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.
Login for BuyandBill.com Analytics
Unlock deeper insights with BuyandBill’s Comparative Report!
- Compare ASP, WAC, and AWP across drugs.
- Visualize Drug Price Movement Over Time
- Tailor reports to drug class, manufacturer, or HCPCS Code.
- Compare Biosimilar and 505(b)(2) products.
Frequently Asked Questions
Is there an available Armlupeg PFS billing and coding guide?
Are there any available Armlupeg patient assistance programs?
Where can I find Armlupeg Pfs prescribing information?
Where can I find Armlupeg Pfs side effect information?
Does billing ARMLUPEG PFS require JZ/JW wastage modifiers?
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.
Related Drug Codes
Explore billing, coding, and pricing for drugs related to Armlupeg PFS.